We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Authorizes Pfizer’s COVID-19 Antiviral Pill
In its first authorization of a COVID-19 antiviral for home use, the FDA yesterday granted Emergency Use Authorization (EUA) to Pfizer’s COVID-19 oral antiviral Paxlovid for adults at high risk of progressing to severe disease, when alternative therapies approved or authorized by FDA are not accessible or clinically appropriate.